Treatments for multi-system inflammatory syndrome in children — discharge, fever, and second-line therapies

Scarce evidence exists about the best treatment for multi-system inflammatory syndrome (MIS-C). We analyzed the effects of steroids, intravenous immunoglobulin (IVIG), and their combination on the probability of discharge over time, the probability of switching to second-line treatment over time, an...

Descripción completa

Detalles Bibliográficos
Autores principales: Tagarro, Alfredo, Domínguez-Rodríguez, Sara, Mesa, Juan Miguel, Epalza, Cristina, Grasa, Carlos, Iglesias-Bouzas, María Isabel, Fernández-Cooke, Elisa, Calvo, Cristina, Villaverde, Serena, Torres-Fernández, David, Méndez-Echevarria, Ana, Leoz, Inés, Fernández-Pascual, María, Saavedra-Lozano, Jesús, Soto, Beatriz, Aguilera-Alonso, David, Rivière, Jacques G., Fumadó, Victoria, Martínez-Campos, Leticia, Vivanco, Ana, Pilar-Orive, Francisco Javier, Alcalá, Pedro, Ruiz, Beatriz, López-Machín, Ana, Oltra, Manuel, Moraleda, Cinta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9595092/
https://www.ncbi.nlm.nih.gov/pubmed/36282324
http://dx.doi.org/10.1007/s00431-022-04649-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9595092/
https://www.ncbi.nlm.nih.gov/pubmed/36282324
http://dx.doi.org/10.1007/s00431-022-04649-8

Ejemplares similares